Serina Therapeutics Inc. (SER) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Serina Therapeutics Inc.

    NYSE: SER · Real-Time Price · USD
    5.24
    -0.01 (-0.19%)
    At close: Oct 03, 2025, 3:41 PM
    5.87
    12.13%
    Pre-market: Oct 06, 2025, 04:24 AM EDT

    Serina Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.31 21.96 -7.93 -33.16
    PEG Ratio
    		 0.01 -0.18 0.11 1.61
    PS Ratio
    		 658.37 36.69 42.53 13.80
    PB Ratio
    		 57.52 21.15 -1.24 -3.54
    P/FCF Ratio
    		 -2.15 -38.82 -10.2 -17.78
    P/OCF Ratio
    		 -2.15 -46.72 -10.25 -18.63
    OCF/S Ratio
    		 -306.02 -0.79 -4.15 -0.74
    Debt / Equity Ratio
    		 0.42 0.80 -0.11 -0.03
    Quick Ratio
    		 2.40 1.29 1.25 3.58
    Current Ratio
    		 2.40 1.29 1.25 3.58
    Asset Turnover
    		 0.01 0.26 0.58 1.65
    Interest Coverage
    		 -32.41 -5.61 -142.99 -527.31
    Return on Equity
    		 -17.38 0.96 0.16 0.11
    Return on Assets
    		 -1.66 0.44 -3.13 -0.69
    Return on Invested Capital
    		 -3.91 -0.19 -4.14 -0.18
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 -2.46 0.97 0.71 -0.04
    Net Profit Margin
    		 -198.95 1.67 -5.36 -0.42
    Pretax Profit Margin
    		 -198.95 1.67 -5.36 -0.42
    Operating Profit Margin
    		 -304.43 -0.99 -4.54 -0.54
    FCF Margin
    		 -306.41 -0.95 -4.17 -0.78
    EBITDA Margin
    		 -187.27 1.88 -14.11 -2.42

    Add to Watchlist